Malignant bowel obstruction

Supportive Oncology

Volumn , Issue , 2011, Pages 326-341

  Correa, Raimundo ^a   Ripamonti, Carla I ^b   Dodge, Jason E ^a,c   Easson, Alexandra M ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882856670     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1015-1.00030-8     Document Type: Chapter

References (138)

1. Dvoretsky P.M., et al. Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer. Hum Pathol 1988, 19:1273-1279.
2. Dvoretsky P.M., et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988, 19:57-63.
3. Ripamonti C., et al. Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 1993, 4:15-21.
4. Rose P.G., et al. Metastatic patterns in histologic variants of ovarian cancer: an autopsy study. Cancer 1989, 64:1508-1513.
5. Idelevich E., et al. Small bowel obstruction caused by secondary tumors. Surg Oncol 2006, 15:29-32.
6. Randall T.C., Rubin S.C. Management of intestinal obstruction in the patient with ovarian cancer. Oncology (Williston Park) 2000, 14:1159-1163. discussion 1167-8, 1171-5.
7. Deans G.T., Krukowski Z.H., Irwin S.T. Malignant obstruction of the left colon. Br J Surg 1994, 81:1270-1276.
8. Fielding L.P., et al. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986, 2:904-907.
9. Pecorelli S., Sartori E., Santin A. Follow-up after primary therapy: management of the symptomatic patient-surgery. Gynecol Oncol 1994, 55:S138-S142.
10. Baines M., Oliver D.J., Carter R.L. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985, 2:990-993.
11. Feuer D.J., et al. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 1999, 75:313-322.
12. Krouse R.S., et al. When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction. J Am Coll Surg 2002, 195:117-128.
13. Averbach A.M., Sugarbaker P.H. Recurrent intraabdominal cancer with intestinal obstruction. Int Surg 1995, 80:141-146.
14. Spears H., et al. Treatment of bowel obstruction after operation for colorectal carcinoma. Am J Surg 1988, 155:383-386.
15. Butler J.A., et al. Small bowel obstruction in patients with a prior history of cancer. Am J Surg 1991, 162:624-628.
16. Edna T.H., Bjerkeset T. Small bowel obstruction in patients previously operated on for colorectal cancer. Eur J Surg 1998, 164:587-592.
17. Ripamonti C., Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 2002, 12:135-143.
18. Roeland E., von Gunten C.F. Current concepts in malignant bowel obstruction management. Curr Oncol Rep 2009, 11:298-303.
19. Marinis A., et al. Intussusception of the bowel in adults: a review. World J Gastroenterol 2009, 15:407-411.
20. Hanan B., et al. Intussusception in adults: a retrospective study. Colorectal Dis 2010, 12:574-578.
21. Wang N., et al. Adult intussusception: a retrospective review of 41 cases. World J Gastroenterol 2009, 15:3303-3308.
22. Krouse R.S. The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research. J Pain Symptom Manage 2007, 34(suppl 1):S1-S6.
23. Anthony T., et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage 2007, 34(suppl 1):S49-S59.
24. Ripamonti C., et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001, 9:223-233.
25. Roberts P.F., Stebbings W.S., Kennedy H.J. Granulomatous visceral neuropathy of the colon with non-small cell lung carcinoma. Histopathology 1997, 30:588-591.
26. Sodhi N., et al. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989, 34:1937-1942.
27. Ripamonti C.I., Easson E.M., Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 2008, 44:1105-1115.
28. Helyer L., Easson A.M. Surgical approaches to malignant bowel obstruction. J Support Oncol 2008, 6:105-113.
29. Burkill G.J., Bell J.R., Healy J.C. The utility of computed tomography in acute small bowel obstruction. Clin Radiol 2001, 56:350-359.
30. Maglinte D.D., et al. Obstruction of the small intestine: accuracy and role of CT in diagnosis. Radiology 1993, 188:61-64.
31. Maglinte D.D., et al. Reliability and role of plain film radiography and CT in the diagnosis of small-bowel obstruction. AJR Am J Roentgenol 1996, 167:1451-1455.
32. Megibow A.J., et al. Bowel obstruction: evaluation with CT. Radiology 1991, 180:313-318.
33. Furukawa A., et al. Helical CT in the diagnosis of small bowel obstruction. Radiographics 2001, 21:341-355.
34. Martin D.R., et al. Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging 2005, 16:77-98.
35. Low R.N., Chen S.C., Barone R. Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MR imaging. Radiology 2003, 228:157-165.
36. Beall D.P., et al. Imaging bowel obstruction: a comparison between fast magnetic resonance imaging and helical computed tomography. Clin Radiol 2002, 57:719-724.
37. Stevenson G. Colon imaging in radiology departments in 2008: goodbye to the routine double contrast barium enema. Can Assoc Radiol J 2008, 59:174-182.
38. Chi D.S., et al. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist 2009, 14:835-839.
39. Pothuri B., et al. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecol Oncol 2004, 95:193-195.
40. Soo K.C., et al. Intestinal obstruction in patients with gynaecological malignancies. Ann Acad Med Singapore 1988, 17:72-75.
41. Bais J.M., et al. Intestinal obstruction in patients with advanced ovarian cancer. Int J Gynecol Cancer 1995, 5:346-350.
42. Castaldo T.W., et al. Intestinal operations in patients with ovarian carcinoma. Am J Obstet Gynecol 1981, 139:80-84.
43. Jong P., Sturgeon J., Jamieson C.J. Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg 1995, 38:454-457.
44. Krebs H.B., Goplerud D.R. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 1983, 61:327-330.
45. Redman C.W., et al. Survival following intestinal obstruction in ovarian cancer. Eur J Surg Oncol 1988, 14:383-386.
46. Ely C.A., Arregui M.E. The use of enteral stents in colonic and gastric outlet obstruction. Surg Endosc 2003, 17:89-94.
47. Ellis C.N., et al. Small bowel obstruction after colon resection for benign and malignant diseases. Dis Colon Rectum 1991, 34:367-371.
48. Katz L.B., et al. Ovarian carcinoma complicated by gastric outlet obstruction. J Surg Oncol 1981, 18:261-264.
49. Larson J.E., et al. Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors. Gynecol Oncol 1989, 35:61-65.
50. Lo N.N., Kee S.G., Nambiar R. Palliative gastrojejunostomy for advanced carcinoma of the stomach. Ann Acad Med Singapore 1991, 20:356-358.
51. Nakane Y., et al. Management of intestinal obstruction after gastrectomy for carcinoma. Br J Surg 1996, 83:113.
52. Rubin S.C., et al. Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol Oncol 1989, 34:16-19.
53. Lau P.W., Lorentz T.G. Results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colorectal cancer. Dis Colon Rectum 1993, 36:61-64.
54. Lund B., et al. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet 1989, 169:213-218.
55. Solomon H.J., et al. Bowel complications in the management of ovarian cancer. Aust N Z J Obstet Gynaecol 1983, 23:65-68.
56. Selby D., et al. Room for improvement? A quality of life assessment in patients with malignant bowel obstruction. Palliat Med 2010, 24:38-45.
57. Bruera E., et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991, 7:6-9.
58. de Haes J.C., van Knippenberg F.C., Neijt J.P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990, 62:1034-1038.
59. Feuer D.J., Broadley K.E. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2000, (2). CD001219.
60. Laval G., et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 2006, 31:502-512.
61. Ripamonti C., et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000, 19:23-34.
62. Mercadante S., Casuccio A., Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage 2007, 33:217-223.
63. Mercadante S., et al. Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage 2004, 28:412-416.
64. Hodge J. The clinical use of the naso-gastric duodenal mercury tip sump tube in abdominal surgery and in the management of intestinal obstruction. Ann Surg 1978, 187:100-102.
65. Meyer L., Pothuri B. Decompressive percutaneous gastrostomy tube use in gynecologic malignancies. Curr Treat Option Oncol 2006, 7:111-120.
66. Dewys W.D., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980, 69:491-497.
67. Bozzetti F., et al. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 1982, 196:170-179.
68. Andreyev H.J., et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998, 34:503-509.
69. Kadar L., et al. The prognostic value of body protein in patients with lung cancer. Ann N Y Acad Sci 2000, 904:584-591.
70. Aviles A., et al. Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 1995, 26:31-34.
71. Blum D., Omlin A., Fearon K., et al. Evolving classification systems for cancer cachexia: ready for clinical practice?. Support Care Cancer 2010, 18:273-279.
72. Braga M., et al. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 2009, 28:378-386.
73. Bozzetti F., et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 2009, 28:445-454.
74. Soo I., Gramlich L. Use of parenteral nutrition in patients with advanced cancer. Appl Physiol Nutr Metab 2008, 33:102-106.
75. The challenge of treating malignant bowel obstruction. J Support Oncol 2006, 4:83-84.
76. Weber C., Zulian G.B. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics. Am J Hosp Palliat Care 2009, 26:84-88.
77. WHO Cancer pain relief 1986, World Health Organization, Geneva, Switzerland.
78. WHO Cancer pain relief 1996, World Health Organization, Geneva, Switzerland. 2nd ed.
79. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?. Cancer Control 2000, 7:149-156.
80. Mercadante S., et al. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993, 7:295-299.
81. Ripamonti C., Mercadante S. How to use octreotide for malignant bowel obstruction. J Support Oncol 2004, 2:357-364.
82. Shinjo T., Kagami R. Radiological imaging change in a malignant bowel obstruction patient treated with octreotide. Support Care Cancer 2009, 17:753-755.
83. Shima Y., et al. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Jpn J Clin Oncol 2008, 38:354-359.
84. Mercadante S., et al. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000, 8:188-191.
85. Mystakidou K., et al. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer Res 2002, 22:1187-1192.
86. Khoo D., et al. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 1994, 30A:28-30.
87. Mangili G., et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 1996, 61:345-348.
88. Massacesi C., Galeazzi G. Sustained release octreotide may have a role in the treatment of malignant bowel obstruction. Palliat Med 2006, 20:715-716.
89. Matulonis U.A., et al. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage 2005, 30:563-569.
90. Jatoi A., et al. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol 2004, 2:323-334;. discussion 334-7.
91. Morrow G., Hickok J., Rosenthal S. Progress in reducing nausea and emesis. Cancer 1995, 76:343-357.
92. Lebrun C., et al. Recurrent bowel occlusion with oral ondasentron with no side effects of the intravenous route: a previously unknown adverse event. Ann Oncol 1997, 8:919-920.
93. Feuer D.J., Broadley K.E. Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee. Ann Oncol 1999, 10:1035-1041.
94. Clark K., Lam L., Currow D. Reducing gastric secretions-a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?. Support Care Cancer 2009, 17:1463-1468.
95. Finan P.J., et al. The management of malignant large bowel obstruction: ACPGBI position statement. Colorectal Dis 2007, 9(suppl 4):1-17.
96. Krouse R.S. Surgical palliation of bowel obstruction. Gastroenterol Clin North Am 2006, 35:143-151.
97. Gauderer M.W., Ponsky J.L., Izant R.J. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 1980, 15:872-875.
98. Ponsky J.L., Gauderer M.W. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc 1981, 27:9-11.
99. Abuksis G., et al. Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am J Gastroenterol 2000, 95:128-132.
100. Chowdhury M.A., Batey R. Complications and outcome of percutaneous endoscopic gastrostomy in different patient groups. J Gastroenterol Hepatol 1996, 11:835-839.
101. Cunliffe D.R., et al. Percutaneous endoscopic gastrostomy at the time of tumour resection in advanced oral cancer. Oral Oncol 2000, 36:471-473.
102. Zera R.T., Nava H.R., Fischer J.I. Percutaneous endoscopic gastrostomy (PEG) in cancer patients. Surg Endosc 1993, 7:304-307.
103. Gutt C.N., et al. Experiences with percutaneous endoscopic gastrostomy. World J Surg 1996, 20:1006-1008. discussion; 1108-9.
104. Gemlo B., et al. Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg 1986, 152:100-104.
105. Hoffer E.K., et al. Radiologic gastrojejunostomy and percutaneous endoscopic gastrostomy: a prospective, randomized comparison. J Vasc Interv Radiol 1999, 10:413-420.
106. Lee M.J., et al. Malignant small bowel obstruction and ascites: not a contraindication to percutaneous gastrostomy. Clin Radiol 1991, 44:332-334.
107. Freeman C., Delegge M.H. Small bowel endoscopic enteral access. Curr Opin Gastroenterol 2009, 25:155-159.
108. Maple J.T., et al. Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts. Am J Gastroenterol 2005, 100:2681-2688.
109. Piccinni G., et al. Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer. Support Care Cancer 2005, 13:535-539.
110. Dohmoto M. Endoscopic implantation of rectal stents in palliative treatment of malignant stenosis (in Japanese). Endosc Dig 1991, 3:1507-1512.
111. Mainar A., et al. Colorectal obstruction: treatment with metallic stents. Radiology 1996, 198:761-764.
112. DeBernardo R. Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Curr Oncol Rep 2009, 11:287-292.
113. Caceres A., et al. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecol Oncol 2008, 108:482-485.
114. Carter J., et al. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents. Gynecol Oncol 2002, 84:176-179.
115. Pothuri B., et al. The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer. Gynecol Oncol 2004, 95:513-517.
116. Keswani R.N., et al. Stenting for malignant colonic obstruction: a comparison of efficacy and complications in colonic versus extracolonic malignancy. Gastrointest Endosc 2009, 69:675-680.
117. Khot U.P., et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002, 89:1096-1102.
118. Sebastian S., et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004, 99:2051-2057.
119. Dronamraju S.S., et al. Role of self-expanding metallic stents in the management of malignant obstruction of the proximal colon. Dis Colon Rectum 2009, 52:1657-1661.
120. Fiori E., et al. Palliative management of malignant rectosigmoidal obstruction: colostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 2004, 24:265-268.
121. Holm A.N., Baron T.H. Palliative use of percutaneous endoscopic gastrostomy and percutaneous endoscopic cecostomy tubes. Gastrointest Endosc Clin N Am 2007, 17:795-803.
122. Caprotti R., et al. Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer. Minerva Gynecol 2006, 58:239-244.
123. Ripamonti C. Management of bowel obstruction in advanced cancer patients. J Pain Symptom Manage 1994, 9:193-200.
124. Pothuri B., et al. Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series. Gynecol Oncol 2003, 89:306-313.
125. Tunca J.C., et al. The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol 1981, 12:186-192.
126. Mangili G., et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer 2005, 15:830-835.
127. Rubin G.P., Devlin H.B. The quality of life with a stoma. Br J Hosp Med 1987, 38:300-303. 306.
128. Smith D.M., et al. Happily hopeless: adaptation to a permanent, but not to a temporary, disability. Health Psychol 2009, 28:787-791.
129. Yau T., et al. Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection. Dis Colon Rectum 2009, 52:669-677.
130. Sinha R., Verma R. Multidetector row computed tomography in bowel obstruction, part 2: large bowel obstruction. Clin Radiol 2005, 60:1068-1075.
131. Sinha R., Verma R. Multidetector row computed tomography in bowel obstruction, part 1: small bowel obstruction. Clin Radiol 2005, 60:1058-1067.
132. Filippone A., Cianci R., Storto M.L. Bowel obstruction: comparison between multidetector-row CT axial and coronal planes. Abdom Imaging 2007, 32:310-316.
133. Jacob S.E., Lee S.H., Hill J. The demise of the instant/unprepared contrast enema in large bowel obstruction. Colorectal Dis 2008, 10:729-731.
134. Lennon A.M., et al. Spiral-enteroscopy-assisted enteral stent placement for palliation of malignant small-bowel obstruction (with video). Gastrointest Endosc 2010, 71:422-427.
135. Bryan D.N., Radbod R., Berek J.S. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer. Int J Gynecol Cancer 2006, 16:125-134.
136. Abu-Rustum N.R., et al. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol 1997, 64:493-495.
137. Ozols R.F., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003, 21:3194-3200.
138. Wasserberg N., Kaufman H.S. Palliation of colorectal cancer. Surg Oncol 2007, 16:299-310.